Clinical Trials Browser

Phase 2 × INDUSTRY × Radiodermatitis × Clear all

NCT07192588 2025-09-25

GuARD

Phase 2 Active not recruiting

Breast Neoplasms, Radiodermatitis

NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Phase 2 Completed

187 enrolled 11 charts

Breast Neoplasms, Inflammation, Radiodermatitis

NCT02289365 2016-06-15

Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms, Radiodermatitis